FDA Inspection
InstaPill Private LimitedInstaPill Private Limited – FDA Inspection, Sep 13, 2024
Record Details
This FDA Inspection record concerns InstaPill Private Limited, with an inspection on September 13, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · e8f69da1-76db-4cb2-bccd-575f3a4a7dee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1249248
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)(1)Sample size - test intervals
Full citation text and observation details available on the Dashboard.
Other FDA inspections of InstaPill Private Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2026 | Not classified | Office of Inspections and Investigations | |
| July 19, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
Other documents for InstaPill Private Limited
- FDA Inspection 1336264 - 2026-08-21
- FDA Inspection 1096764 - 2019-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.